Cipta Sarana Medika Tbk. vs Supra Boga Lestari Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp64 (market cap 160.67B, 20.32M 24h volume), while Supra Boga Lestari Tbk. trades at Rp525 (market cap 813.53B, 4.8K 24h volume). The key difference: Supra Boga Lestari Tbk. is far larger — about 5.1× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (20.32M versus 4.8K). Which is the better fit depends on your goals.
| DKHH | RANC | |
|---|---|---|
Market Cap | 160.67B | 813.53B |
Volume | 20.32M | 4.8K |
Lot | 203.24K | 48 |
Turnover | 1.33B | 2.52M |
Average Price | 65.3 | 525 |
Value | 1.33B | 2.52M |
Indicative Equilibrium Price | 64 | 525 |
Indicative Equilibrium Volume | 1.35K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Supra Boga Lestari Tbk (the Company) was established in Indonesia based on Notarial Deed No. 34 of Suwarni Sukiman, S.H., dated May 28, 1997.
Read more on RANC →